Alcohol septal ablation in patients with severe septal hypertrophy
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
31471463
DOI
10.1136/heartjnl-2019-315422
PII: heartjnl-2019-315422
Knihovny.cz E-zdroje
- Klíčová slova
- alcohol septal ablation, hypertrophic cardiomyopathy, outflow gradient, prognosis, survival,
- MeSH
- časové faktory MeSH
- dospělí MeSH
- ethanol * MeSH
- hypertrofická kardiomyopatie terapie MeSH
- hypertrofie levé komory srdeční terapie MeSH
- hypertrofie terapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mezikomorová přepážka patologie MeSH
- retrospektivní studie MeSH
- senioři MeSH
- stupeň závažnosti nemoci MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- ethanol * MeSH
OBJECTIVE: The current guidelines suggest alcohol septal ablation (ASA) is less effective in hypertrophic obstructive cardiomyopathy (HOCM) patients with severe left ventricular hypertrophy, despite acknowledging that systematic data are lacking. Therefore, we analysed patients in the Euro-ASA registry to test this statement. METHODS: We compared the short-term and long-term outcomes of patients with basal interventricular septum (IVS) thickness <30 mm Hg to those with ≥30 mm Hg treated using ASA in nine European centres. RESULTS: A total of 1519 patients (57±14 years, 49% women) with symptomatic HOCM were treated, including 67 (4.4%) patients with IVS thickness ≥30 mm. The occurrence of short-term major adverse events were similar in both groups. The mean follow-up was 5.4±4.3 years and 5.1±4.1 years, and the all-cause mortality rate was 2.57 and 2.94 deaths per 100 person-years of follow-up in the IVS <30 mm group and the IVS ≥30 mm group (p=0.047), respectively. There were no differences in dyspnoea (New York Heart Association class III/IV 12% vs 16%), residual left ventricular outflow tract gradient (16±20 vs 16±16 mm Hg) and repeated septal reduction procedures (12% vs 18%) in the IVS <30 mm group and IVS ≥30 mm group, respectively (p=NS for all). CONCLUSIONS: The short-term results and the long-term relief of dyspnoea, residual left ventricular outflow obstruction and occurrence of repeated septal reduction procedures in patients with basal IVS ≥30 mm is similar to those with IVS <30mm. However, long-term all-cause and cardiac mortality rates are worse in the ≥30 mm group.
Cardiocentre Podlesi Trinec Czech Republic
Department of Cardiology Gentofte Hospital Copenhagen University Hospital Hellerup Denmark
Department of Cardiology St Antonius Hospitalen Nieuwegein Nieuwegein The Netherlands
Department of Internal Medicine Juliusspital Wuerzburg Wuerzburg Germany
Department of Interventional Cardiology and Angiology Institute of Cardiology Warsaw Poland
Institute of Cardiovascular Medicine and Science Liverpool Heart and Chest Hospital Liverpool UK
Ural Federal University Sverdlovsk Russian Federation
Yekaterinburg Regional Hospital No 1 Yekaterinburg Russian Federation
Citace poskytuje Crossref.org